Ecolab (ECL) Investor presentation summary

Unique business model and market leadership

• Global leader in water, hygiene, and infection prevention, serving 170+ countries and 40 industries.

• Delivers strong top-line growth through powerful core businesses and high-growth engines.

• Focuses on value pricing and high-margin segments for significant margin expansion.

• Protects people and natural resources, aiming for a cleaner, safer, healthier world.

Financial performance and targets

• Achieved $16B in 2025 sales with a 6% CAGR since 2021.

• Targets 5-7% organic sales growth and 12-15% adjusted EPS growth annually.

• Operating income margin expected to exceed 20%, expanding by 100-150 bps per year.

• Free cash flow conversion of 90-100% of net income, supporting dividends, acquisitions, and share repurchases.

Diversified revenue and growth opportunities

• Revenue diversified across Institutional & Specialty, Life Sciences, Pest Elimination, and High-Tech segments.

• Over 90% of revenue comes from consumable, mission-critical solutions.

• Significant growth opportunity with $60B potential from existing customers and $89B from unsold customers.